Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0001493152-23-007662

Chief Financial Officer acquired 26,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coveney Kevin Michael Chief Financial Officer 2023-03-13 Grant or award +26,500 26,500 D
Loading xslF345X03/ownership.xml…